Medical Launch Readiness in a Virtual World
From RWE generation to the delivery of personalised medical information, digital technology is enabling medical affairs to take a central role in product launch preparation. But is pharma getting full value from its medical affairs team? Why should medical affairs be engaged early? How are digital technologies transforming pre and post launch KOL/HCP interactions? Which digital KPIs reveal the value of medical affairs’ work? In this report medical affairs professionals reveal the developments and strategies that are underpinning drug launch success.
Companies
Novartis, Sanofi, Pfizer, Google, Otsuka Pharmaceuticals, Verily Life Sciences, Boehringer Ingelheim, IQVIA, Evermed, Deloitte, Homburg & Partners
- Subject synopsis
- Research methodology and objectives
- Experts interviewed
- Key research objectives
- Key insights summary
- Issues and insights
- Best practices for Medical Affairs in medical launch readiness
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Establishing and monitoring KPIs for medical launch readiness
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Optimising stakeholder interaction and communication for medical launch readiness
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Future outlook: Medical launch readiness in a virtual world
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook